Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers

NCT03565861 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety Issues

Interventions

DRUG: Placebo
DRUG: NP10679

Sponsor

Neurop Inc.